Superdisintegrants Strategic Business Report 2025: Market to Reach $567.2 Million by 2030 - Emergence of Natural and Biodegradable Superdisintegrants Propels Competitiveness
DUBLIN--(BUSINESS WIRE)--May 30, 2025--
The 'Superdisintegrants - Global Strategic Business Report' report has been added to ResearchAndMarkets.com's offering.
The global market for Superdisintegrants was valued at US$414.5 Million in 2024 and is projected to reach US$567.2 Million by 2030, growing at a CAGR of 5.4% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Superdisintegrants market.
Superdisintegrants play a critical role in enhancing the performance of pharmaceutical dosage forms, particularly in the manufacturing of orally disintegrating tablets (ODTs) and fast-release formulations. These excipients accelerate the breakdown of tablets when they come into contact with water or bodily fluids, allowing for faster drug release and absorption.
The growing preference for ODTs, especially among pediatric and geriatric patients who may have difficulty swallowing conventional tablets, has led to a surge in demand for superdisintegrants. Pharmaceutical manufacturers rely on superdisintegrants like crospovidone, sodium starch glycolate, and croscarmellose sodium to improve the efficiency and efficacy of their drug formulations, particularly for over-the-counter (OTC) and prescription medications.
What Drives Growth in the Superdisintegrants Market?
The growth in the Superdisintegrants market is driven by several factors, including the increasing demand for fast-acting and patient-friendly drug formulations, advancements in drug delivery systems, and the rising prevalence of chronic diseases that require ongoing medication. The growing pediatric and geriatric populations, who benefit the most from orally disintegrating tablets, are also fueling demand.
Additionally, regulatory support for improving patient compliance and the increasing popularity of nutraceuticals and dietary supplements are expanding the application of superdisintegrants. The focus on innovation, particularly in natural and multifunctional superdisintegrants, is contributing to sustained market growth.
What Are the Latest Innovations in Superdisintegrants?
Advancements in superdisintegrant technology are focused on improving the efficiency, compatibility, and safety of these excipients. Recent innovations include the development of natural and biodegradable superdisintegrants, which are gaining popularity due to their eco-friendly nature. Additionally, pharmaceutical companies are experimenting with multifunctional superdisintegrants that offer not only rapid disintegration but also improved drug stability and bioavailability.
The rise of novel drug delivery systems, such as sublingual and buccal tablets, has further expanded the scope of superdisintegrants in modern formulations. Continuous R&D efforts are aimed at reducing disintegration times and optimizing the functionality of these excipients in different drug matrices.
Which Market Segments Are Leading in Superdisintegrants?
Key product types include synthetic superdisintegrants such as crospovidone and sodium starch glycolate, which dominate the market due to their high efficiency. Natural superdisintegrants like modified starches and cellulose are gaining traction as clean-label options for pharmaceutical companies. In terms of formulation, orally disintegrating tablets (ODTs) and fast-release capsules account for the largest share of the market.
The pharmaceutical sector is the primary end-user of superdisintegrants, with applications in both prescription and OTC drugs. North America and Europe hold the largest market shares due to the advanced pharmaceutical infrastructure, while Asia-Pacific is expected to witness rapid growth due to increasing drug production.
Report Scope
Key Insights:
Report Features:
Segments
Tariff Impact Analysis: Key Insights for 2025
What's Included in This Edition:
Buyers receive a free July 2025 update with:
Key Attributes:
Key Topics Covered:
MARKET OVERVIEW
MARKET TRENDS & DRIVERS
FOCUS ON SELECT PLAYERS: Some of the 46 companies featured in this report
For more information about this report visit https://www.researchandmarkets.com/r/4356ss
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
View source version on businesswire.com:https://www.businesswire.com/news/home/20250530004203/en/
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
KEYWORD:
INDUSTRY KEYWORD: CHEMICALS/PLASTICS MANUFACTURING
SOURCE: Research and Markets
Copyright Business Wire 2025.
PUB: 05/30/2025 12:14 PM/DISC: 05/30/2025 12:13 PM
http://www.businesswire.com/news/home/20250530004203/en
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
6 hours ago
- Yahoo
Inside key meeting to remove Trump tariffs
Trade Minister Don Farrell has detailed the discussion he had with his US counterpart Jamieson Greer, revealing he had the 'greatest confidence' in Anthony Albanese during an expected meeting with Donald Trump next weekend. Senator Farrell spoke to the US Trade Representative while in Paris last week and characterised the talk as 'friendly'. Despite this, he maintained the tariffs were 'simply unjustified', highlighting Australia's trade surplus with the US. Figures indicate Australia buys about $70bn worth of goods from the US, compared to the $30bn of exports Australia sells to America. 'It wasn't a difficult discussion in terms of the relationship between us, and I am certainly of the view that we have the opportunity to continue to talk with Jamieson and Commerce Secretary Lutnick to put our case across,' he said. Senator Farrell also said he was still determined to get the trade barriers slashed. 'It's only by open discussion, honest discussion, with our allies in the United States that I think we can do that, but I certainly haven't given up on the prospect of getting these tariffs removed,' he said. 'And every opportunity I get, I'll continue to pursue that argument with the United States.' However, Senator Farrell said the decision will be ultimately made by Donald Trump, putting increased pressure on Mr Albanese's upcoming meeting with the US President. He said that while there were a 'range of ways' in which Australia communicates with the US, the 'most important … relationship between our prime minister and the president of the United States'. 'Look every meeting, I think, between an Australian Prime Minister and the US president will always be a critical meeting and I have the greatest confidence in our prime minister to push the Australian point of view on this.' The trade barriers currently include a 50 per cent levy on steel, a 25 per cent tariffs on aluminium and a blanket 10 per cent on other goods. While Mr Albanese maintained he won't compromise on Australia's biosecurity, he hinted Australia could review current settings which don't allow the US to import beef which originates from Canada and Mexico. Mr Albanese has also ruled out changes to the Pharmaceuticals Benefit Scheme, News Media Bargaining code and incoming ban on social media for under-16s, while highlighting Australia's critical minerals industry as a potential bargaining chip. 'If things can be sorted out in a way that protects our biosecurity – of course, we don't just say no, we don't want imports in here for the sake of it,' he told ABC radio on Friday. 'But our first priority is biosecurity and there'll be no compromise on that.' Mr Albanese said Australia would not have a 'subservient relationship to any nation'. 'We're a sovereign nation that stand on our own two feet,' he said. Senator Farrell also said he was 'confident' Australia can secure a new trade deal with the European Union, with EU President Ursula von der Leyen expected to visit Australia in July or August. 'We've got lots of things that we can sell to the to the Europeans. I believe now that there's an appetite to reach an agreement on both sides,' he said. 'The world has changed, those countries that believe in free and fair trade have to work together.'
Yahoo
7 hours ago
- Yahoo
'Haven't given up': minister seeks tariff breakthrough
Australia's trade minister remains confident tariffs imposed by the US will be removed, ahead of a likely meeting between Anthony Albanese and Donald Trump. The two leaders could meet on the sidelines of the G7 summit in Canada next week, with the economic measures imposed by the US president around the world set to dominate discussions. As Australia looks to negotiate for an exemption on tariffs, Trade Minister Don Farrrell was optimistic a deal could be reached. "I certainly haven't given up on the prospect of getting these tariffs removed, and every opportunity I get, I'll continue to pursue that argument with the United States," he told Sky News on Sunday. "There is no justification for the United States to impose tariffs on Australia ... we want all of the tariffs removed, not just some of them." Mr Trump recently signed off on doubling tariffs on exports on steel and aluminium from 25 to 50 per cent. All other Australian exports to the US have been slapped with a 10 per cent tariff. Senator Farrell met with US trade representative Jamieson Greer last week and said he pushed the case for all of the economic measures to be removed. The minister was hopeful a similar approach that removed $20 billion worth of tariffs on Australian goods entering China could be used with America. "We didn't retaliate on that occasion, and bit by bit, we managed to get all of those tariffs that had been applied on Australia by China removed. I'd like to do the same with the United States," he said. "It's only by open discussion, honest discussion with out allies in the United States that I think we can do that." As the US Defence Secretary Pete Hegseth urged Australia to increase its defence spending by billions of dollars to 3.5 per cent of GDP, Senator Farrell said the federal government had already proved its commitment through the AUKUS submarine deal. Australia is looking to up its total spent on defence to 2.3 per cent. "We are committed to the defence of this country, we are committed to a significant uplift in the amount of spending," Senator Farrell said. "(AUKUS) is going to be a project that's worth more than $360 billion, so I think we've talked the talk." Prime Minister Anthony Albanese signalled on Friday negotiations on opening up access to US beef into Australia could be on the table as part of tariff negotiations. However, he said biosecurity would not be compromised in order to reach an agreement.
Business Wire
11 hours ago
- Business Wire
ABL Investors Have Opportunity to Join Abacus Global Management, Inc. Fraud Investigation with the Schall Law Firm
LOS ANGELES--(BUSINESS WIRE)-- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Abacus Global Management, Inc. ('Abacus' or 'the Company') (NASDAQ: ABL) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Abacus is the subject of a report issued by Morpheus Research on June 4, 2025, titled: 'Abacus Global Management: This $794 Million SPAC Is Yet Another Life Settlements Accounting Scheme Manufacturing Fake Revenue by Systematically Underestimating When People Will Die.' According to the report, the Company changed its portfolio valuation methodology to make it appear more profitable than it actually is. The report also alleges that the Company uses unusual methodologies to calculate life expectancy estimates and its co-founders have 'red flags' in their past. If you are a shareholder who suffered a loss, click here to participate. We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at or by email at bschall@ The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
